Presbyopia-correcting ICL · BGSS

Viva ICL for Presbyopia in Busan, Korea

A presbyopia-correcting implantable lens for people over 40 who want clear vision near and far without reading glasses, while keeping their own natural lens. Dr. Jong-Ho Lee was the first surgeon in Korea to perform Viva ICL.

Age 40+ presbyopia 9 in 10 glasses-free daily vision* First in Korea Viva ICL
9 in 10+ Glasses-free daily vision*
83% 20/25 or better at 1 month*
98%+ Best-corrected 20/25 at 3 months*
29 yrs Presbyopia research
What is Viva ICL?

Viva ICL, explained in one minute

Viva ICL is an implantable collamer lens designed for presbyopia, the age-related loss of near focus. Placed in front of your natural lens, it corrects near, intermediate and distance vision together, so daily tasks need fewer or no glasses.

Unlike cataract surgery, Viva ICL keeps your natural lens and does not remove corneal tissue. It can also correct nearsightedness at the same time, and cataract surgery remains possible later in life.

BGSS has researched presbyopia correction since 1997, from early techniques to today’s lens-based options.

Why patients choose Viva ICL

Benefits of Viva ICL

01

Near and far

Corrects reading, computer and distance vision together.

02

Keeps your natural lens

No lens removal, and cataract surgery is still possible later.

03

No corneal tissue removed

Suitable for thin corneas and after previous laser surgery.

04

UV protection

The collamer lens blocks UV light.

05

Removable

The lens can be removed if needed.

06

Follow-up programme

BGSS offers a follow-up warranty programme.

Am I a candidate?

Who Viva ICL suits

Viva ICL may suit you if you:

  • Are 40 or older and need reading glasses
  • Want to reduce dependence on glasses for near and far
  • Have thin corneas or high myopia
  • Have had LASIK or LASEK before
  • Do not yet have a cataract that needs surgery

Eligibility is confirmed after a full presbyopia and lens examination.

For international patients

Your Viva ICL trip to Busan

BGSS is a registered facility for international patients. Our coordinators speak English and Chinese and arrange your schedule before you arrive. Appointments are by reservation only.

Before you fly Message us

Send your prescription or medical records and travel dates on WhatsApp or KakaoTalk. A coordinator replies with a suggested schedule.

Visit 1 Full eye exam

Detailed diagnostic tests and a consultation with your doctor, who confirms the safest option for your eyes.

Treatment day Your Viva ICL

Your treatment is carried out by your BGSS doctor. Plan a quiet rest of the day.

Next day Follow-up check

Your doctor checks healing and vision, explains your eye drops, and confirms when you can travel home.

How long to stay in Busan depends on your exam results and the follow-up your doctor recommends. Please confirm your flight dates with your coordinator before booking.

Recovery

Recovery after Viva ICL

From BGSS’s official aftercare guidance; your doctor gives personal instructions.

First 3–4 hours

Watering or mild pain is common.

Days 3–5

Travel after 3–4 days; face washing after 5 days.

First 2 weeks

Wear goggles while sleeping; light exercise after 2 weeks; night driving after 1–2 weeks.

First 2 months

Makeup after 1 month; strenuous exercise and sauna after 2 months. Any haze settles over 2–3 months.

Dr. Jong-Ho Lee, founder of BGSS Eye Clinic in Busan, Korea
Dr. Jong-Ho Lee Founder & CEO · M.D., Ph.D.

Appointed ICL instructor in 2006 and the first surgeon in Korea to perform Viva ICL. Has researched presbyopia correction since 1997.

Why BGSS Eye Clinic

Trusted in Busan since 1997

  • Korea’s first generation of vision correction BGSS opened in Busan in 1997 and has performed more than 628,000 procedures in Seoul and Busan, including 330,000+ in Busan.
  • Every major option under one roof SMILE Pro, SMILE, LASIK, LASEK, ICL, cataract and presbyopia surgery, so your doctor can recommend what truly suits your eyes.
  • Advanced diagnostics Pentacam, CASIA2, Galilei G4, OCT, UBM and more are used to measure your eyes before any treatment.
  • Government-recognised Designated by Korea’s Ministry of Health and Welfare as an advanced regenerative medicine institution, and registered for international patients.
  • Central Seomyeon location Ion City Building, near Seomyeon Station Exit 7, with care in English and Chinese.
FAQ

Viva ICL in Busan: frequently asked questions

What is Viva ICL?

Viva ICL is an implantable collamer lens that corrects presbyopia, giving near, intermediate and distance vision while keeping your natural lens.

Who is Viva ICL for?

It is designed for people aged 40 and over with presbyopia, including those with thin corneas, high myopia or previous LASIK or LASEK.

What results has BGSS seen with Viva ICL?

Results presented at the 2025 VIVA ICL User Meeting: more than 9 in 10 patients had glasses-free daily vision, 83% saw 20/25 or better unaided at one month, and over 98% had best-corrected 20/25 or better at three months.

How is Viva ICL different from cataract surgery?

Viva ICL keeps your natural lens; cataract surgery replaces it. Cataract surgery is still possible later.

How long should I stay in Busan?

Travel is usually possible after 3–4 days. Your doctor confirms your schedule.

Should I stop wearing contact lenses before the exam?

Yes: soft lenses 1 week, toric soft lenses 2 weeks and ortho-K lenses at least 4 weeks before.

Visit BGSS Busan

Book your Viva ICL consultation

Send us your prescription and travel dates. Our international team will reply with a suggested schedule.

Appointments are by reservation only. We do not accept walk-in patients.

  • Address 74 Seomyeon-ro, Busanjin-gu, Busan
    Ion City Bldg 8–11F · Seomyeon Station Exit 7
  • International Desk +82-10-7632-8782
  • Busan Clinic +82-51-805-1100
  • Mon · Tue · Thu · Fri 09:00 – 18:00 (lunch 13:00–14:00)
  • Saturday 09:00 – 16:00
  • Wed · Sun · Holidays Closed
*Viva ICL results presented by BGSS at the 2025 VIVA ICL User Meeting and the 2025 Korea EVO ICL Forum. Case numbers are BGSS Eye Clinic data as of December 2025 (628,000+ procedures in Seoul and Busan; 330,000+ in Busan). Treatment outcomes vary by patient, and your ophthalmologist will confirm your suitability after a full examination.